Skip to main content
logo
Wai Chun Bio-Technology Limited (HKG:0660)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3850
+0.0050 (1.32%)
Sep 2, 2026, 4:08 PM HKT

Wai Chun Bio-Technology Financials Overview

Millions HKD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Dec '21
Revenue
568.26377.17370.07773.65671.46495.38
Revenue Growth
50.67%1.92%-52.17%15.22%35.55%-12.72%
Gross Profit
50.533634.1850.4160.1237.58
Operating Income
6.283.731.6211.9217.991.62
Net Income
-6.9-14.62-44.21-15.43-14.36-17.03
Earnings Per Share
-0.04-0.08-0.26-0.09-0.09-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Dec '21
Cash & Investments
23.926.562.166.317.5225.3
Total Debt
141.8795.19135.9134.34151.28147.37
Net Cash (Debt)
-117.96-88.63-133.74-128.02-143.76-122.07
Net Cash Growth
------
Net Cash Per Share
-0.67-0.51-0.78-0.76-0.86-0.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Dec '21
Operating Cash Flow
23.781.4252.0948.893.19-9.4
Capital Expenditures
-25.54-25.54-40.05-28.18-11.19-0.3
Free Cash Flow
-1.76-24.1212.0520.71-8.01-9.7
Free Cash Flow Growth
---41.84%---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Dec '21
Gross Margin
8.89%9.55%9.24%6.52%8.95%7.58%
Operating Margin
1.10%0.99%0.44%1.54%2.68%0.33%
Pretax Margin
-0.18%-2.37%-21.12%-0.74%0.38%-2.26%
Profit Margin
-1.21%-3.88%-11.95%-1.99%-2.14%-3.44%
FCF Margin
-0.31%-6.40%3.26%2.68%-1.19%-1.96%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Jun '25 Jun '24 Jun '23 Jun '22 Dec '21
P/FCF Ratio
--1.780.84--
PS Ratio
0.250.070.060.020.100.19